Featured Speakers

Carl June
Richard W. Vague Professor in Immunotherapy; Director, Center for Cellular Immunotherapies, Perelman School of Medicine Director, Parker Institute Cancer Immunotherapy; University of Pennsylvania USA

Carl June
Richard W. Vague Professor in Immunotherapy; Director, Center for Cellular Immunotherapies, Perelman School of Medicine Director, Parker Institute Cancer Immunotherapy; University of Pennsylvania USA
Jennifer Brogdon
Executive Director, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, USA

Jennifer Brogdon
Executive Director, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research, USA
Stanley Riddell
Stanley Riddell Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center, Professor, Department of Medicine at the University of Washington USA

Stanley Riddell
Stanley Riddell Director, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center, Professor, Department of Medicine at the University of Washington USA
Nicholas Restifo
Executive VP, Research, Lyell Immunopharma Inc.,USA

Nicholas Restifo
Executive VP, Research, Lyell Immunopharma Inc.,USA
Meet All of Our Speakers
Print Friendly, PDF & Email

A must-attend event

With ground-breaking clinical success and exponentially growing research leading to FDA approved products, lymphocyte engineering is the way of the future. Be part of it! Join us for the 2nd International Conference on Lymphocyte Engineering - where the world`s health innovators in immuno-gene therapy come together.

Print Friendly, PDF & Email

The ICLE Advantage

We laid the foundations of a strong community across industry and academia dedicated to lymphocyte engineering. Join us as we lead the future of the field.

128-facebook
128-twitter
128-linkedin
  • ICLE-2018-13
  • ICLE-2018-22
  • ICLE-2018-27
  • ICLE-2018-19
  • ICLE-2018-2 (1)
  • ICLE-2018-4
Facebook Twitter Google Plus
Print Friendly, PDF & Email

One of the cornerstone conferences in lymphocyte engineering in the world

I very much enjoyed the conference. Top quality, top attendees and great exchanges. It could become one of the cornerstone conferences in lymphocyte engineering in the world.
André Choulika - CEO Cellectis

An outstanding set of speakers

An outstanding set of speakers that were really state of the art…. We could establish collaborations and I have done that here myself
Carl June - Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine

Exposure to a diversity of approaches in lymphocyte engineering

The benefit of attending the conference is the exposure to a diversity of approaches in lymphocyte engineering and the opportunity to network with some of the best people in the world working in those fields.
Andrew Scharenberg - CSO Casebia Therapeutics
Print Friendly, PDF & Email

Frequently asked questions

Check out the FAQs to find the answers to common questions. Can't find your question answered here? Contact Us.

What I need to know before I submit my abstract?

The abstract submission deadline is Wednesday, 22 May 2019 

All accepted abstracts are scheduled in the Scientific Programme as Poster, e-Poster or Oral presentations. It is expected that at least one author of the abstract attends the meeting to present the work and answer questions. Only abstracts of registered participants will be scheduled in the Scientific Programme.

You may enter the Abstract Submission system with your username and password and make changes to your abstract until the submission deadline date. No abstract changes will be accepted after this date, however, you are welcome to present more updated information as part of your poster at the conference.

Copies of your accepted and registered abstracts will be published on the conference website.

When is the Early Bird deadline for registration?

Register before Wednesday, 19 June 2019 and save on the Early Bird Rates!

Registration will be opened soon.

Payment of registration fees can be made by credit card or bank transfer. For full details please click here.

In order to benefit from the early fee registration discount, payment must be received before the deadline.

A detailed confirmation letter and receipt will be sent to you by email as soon as payment is received and registration is completed. You may use this confirmation letter for visa application purposes.

How can I reserve a room at a special rate?

We are offering conference participants specially reduced rates at the conference venue hotel. Information, pictures, location and rates are available on the hotel accommodation page.

For group booking (10 rooms and more) please contact us. Different payment and cancellation conditions apply.

How can I support the conference?

ICLE 2019 is the best place to position your company and organization!

ICLE 2018 in numbers:
• 200+ participants
• 26 countries

• Professional interest:
– 55% immunology
– 35% cell & gene therapy
– 11% oncology

• Professional role:
– Clinician Researcher 6%
– Academic 40%
– Industry/Corporate Professional 15%
– Other 9%
– Resident/Research Fellow 30%

Key Dates

Abstracts:
Early Submission Deadline 22 May 2019
Late Submission Deadline 10 July 2019
Early Abstract Review Late May 2019
Late Abstract Review Mid July 2019
Early Notifications sent to Presenters Early June 2019
Late Notifications sent to Presenters Early August 2019

Registration:
Early Bird Registration Deadline 19 June 2019
Regular Fee From 20 June 2019
On Site Fee From 29 August 2019

Registration Cancellation Policy:
100% refund June 19, 2019
50% refund From  June 20, 2019 until September 03, 2019
No refund From September 04, 2019

Print Friendly, PDF & Email

We’ve got news!

Subscribe and be the first to know about updates to the program and important developments

Print Friendly, PDF & Email

Event Location

Here, you will find directions to the conference venue. More space to meet and network!

Novotel London West
Print Friendly, PDF & Email